Research progress on the at-risk category and stage 0 of medication-related osteonecrosis of the jaw
Medication-related osteonecrosis of the jaw (MRONJ) is a metabolic disorder and a form of jaw osteonecrosis that arises from the use of bisphosphonates, anti-angiogenic drugs, and other medications in the treatment of conditions such as malignant tumor bone metastasis and osteoporosis. The American...
Saved in:
| Main Authors: | YANG Mu, KANG Feiwu, ZHANG Xueming |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Oral and Maxillofacial Surgery
2025-02-01
|
| Series: | Kouqiang hemian waike zazhi |
| Subjects: | |
| Online Access: | https://journal06.magtech.org.cn/Jweb_joms/EN/10.12439/kqhm.1005-4979.2025.01.009 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuralgia Inducing Cavitational Osteonecrosis of the Jaw: Scientific Controversy or pseudoscience?
by: Keith DA
Published: (2025-08-01) -
Endodontic therapy and Medication-related osteonecrosis of the jaw onset: a scoping review and expert opinion-based qualitative meta-synthesis
by: R. Mauceri, et al.
Published: (2025-08-01) -
Incidence of medication-related osteonecrosis of the jaw and associated antiresorptive drugs in adult Finnish population
by: Miika Kujanpää, et al.
Published: (2025-05-01) -
Surgical extraction with photobiomodulation as an adjunctive modality in patients at-risk for medication-related osteonecrosis of the jaw: retrospective study
by: Gianluca Tenore, et al.
Published: (2025-04-01) -
Quantitative indices for cone-beam CT assessment of Medication-Related Osteonecrosis of the Jaw – a scoping review
by: Ghaidaa Badabaan, et al.
Published: (2023-02-01)